FNAM OTC
Evolutionary Genomics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
+1.7% ▲
Operating Income
-$2M
+30.0% ▲
Net Income
-$2M
+30.7% ▲
EPS (Diluted)
$-0.35
+32.7% ▲
EBITDA
-$913K
+48.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $115K | $123K | $12K | $0 | $0 |
| YoY Growth | +251.2% | +6.9% | -89.8% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $206K | $2K | $1M | $1M |
| Gross Profit | $115K | -$83K | -$2M | -$1M | -$1M |
| Gross Margin | 100.0% | -67.8% | -14245.2% | — | — |
| R&D Expenses | $474K | $473K | $2M | $1M | $417K |
| SG&A Expenses | $478K | $425K | $1M | $2M | $575K |
| Operating Expenses | $952K | $898K | $1M | $2M | $993K |
| Operating Income | -$837K | -$775K | -$3M | -$3M | -$2M |
| Operating Margin | -728.8% | -631.6% | -23038.4% | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$1M | -$761K | -$3M | -$3M | -$2M |
| Tax Expense | $0 | $32K | -$987K | $0 | $0 |
| Net Income | -$1M | -$793K | -$2M | -$3M | -$2M |
| Net Margin | -956.9% | -646.5% | -13695.1% | — | — |
| EPS (Diluted) | $-0.19 | $-0.13 | $-0.34 | $-0.52 | $-0.35 |
| EBITDA | -$796K | -$734K | -$2M | -$2M | -$913K |
| Shares Outstanding | 6M | 6M | 6M | 6M | 6M |